ONESOURCEPharmaceuticals
OneSource Specialty Pharma Inc — Balance Sheet
₹1473.30
+8.47%
OneSource Specialty Pharma Inc Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Liabilities Net Minority Interest | 1.67K Cr | 912.90 Cr | 1.22K Cr |
| Total Non Current Liabilities Net Minority Interest | 556.10 Cr | 282.31 Cr | 358.14 Cr |
| Other Non Current Liabilities | 1.19 Cr | — | — |
| Non Current Deferred Taxes Liabilities | 155.22 Cr | — | — |
| Long Term Debt And Capital Lease Obligation | 382.52 Cr | 279.91 Cr | 355.99 Cr |
| Long Term Capital Lease Obligation | 163.19 Cr | 8.32 Cr | 21.11 Cr |
| Long Term Debt | 219.33 Cr | 271.59 Cr | 334.88 Cr |
| Long Term Provisions | 15.79 Cr | 2.40 Cr | 2.15 Cr |
| Current Liabilities | 1.11K Cr | 630.59 Cr | 865.22 Cr |
| Other Current Liabilities | 252.59 Cr | 5.96 Cr | 5.96 Cr |
| Current Debt And Capital Lease Obligation | 559.91 Cr | 291.26 Cr | 508.23 Cr |
| Current Capital Lease Obligation | 7.66 Cr | 0.69 Cr | 6.41 Cr |
| Current Debt | 552.26 Cr | 290.57 Cr | 501.82 Cr |
| Current Provisions | 12.23 Cr | 4.30 Cr | 3.58 Cr |
| Payables | 187.23 Cr | 223.85 Cr | 293.27 Cr |
| Total Tax Payable | 11.72 Cr | — | — |
| Accounts Payable | 175.51 Cr | 81.02 Cr | 94.82 Cr |
| Total Assets | 7.55K Cr | 1.31K Cr | 2.01K Cr |
| Total Non Current Assets | 6.46K Cr | 1.13K Cr | 1.78K Cr |
| Other Non Current Assets | 47.09 Cr | — | — |
| Non Current Prepaid Assets | 17.90 Cr | 4.91 Cr | 12.45 Cr |
| Investmentin Financial Assets | 6.91 Cr | 3.79 Cr | 0.00 |
| Available For Sale Securities | 6.91 Cr | — | — |
| Goodwill And Other Intangible Assets | 5.38K Cr | 325.45 Cr | 337.71 Cr |
| Other Intangible Assets | 1.55K Cr | 325.45 Cr | 337.71 Cr |
| Goodwill | 3.83K Cr | — | — |
| Net PPE | 957.73 Cr | 743.52 Cr | 1.37K Cr |
| Gross PPE | 957.73 Cr | 1.00K Cr | 1.63K Cr |
| Construction In Progress | 60.37 Cr | 61.09 Cr | 202.52 Cr |
| Other Properties | 897.35 Cr | — | — |
| Current Assets | 1.09K Cr | 176.38 Cr | 228.40 Cr |
| Other Current Assets | 170.41 Cr | — | — |
| Prepaid Assets | 0.12 Cr | 15.06 Cr | 4.57 Cr |
| Inventory | 158.06 Cr | 11.23 Cr | 133.16 Cr |
| Accounts Receivable | 416.60 Cr | 55.24 Cr | 3.82 Cr |
| Cash Cash Equivalents And Short Term Investments | 340.99 Cr | 22.26 Cr | 9.47 Cr |
| Other Short Term Investments | 184.52 Cr | 15.79 Cr | 4.50 Cr |
| Cash And Cash Equivalents | 156.48 Cr | 6.47 Cr | 4.97 Cr |
| Ordinary Shares Number | 11.44 Cr | 11.44 Cr | 11.44 Cr |
| Share Issued | 11.44 Cr | 11.44 Cr | 11.44 Cr |
| Net Debt | 615.11 Cr | 555.69 Cr | 831.72 Cr |
| Total Debt | 942.44 Cr | 571.17 Cr | 864.22 Cr |
| Tangible Book Value | 502.37 Cr | 70.27 Cr | 447.75 Cr |
| Invested Capital | 6.65K Cr | 957.88 Cr | 1.62K Cr |
| Working Capital | -27.38 Cr | -454.21 Cr | -636.81 Cr |
| Net Tangible Assets | 502.37 Cr | 70.27 Cr | 447.75 Cr |
| Capital Lease Obligations | 170.85 Cr | 9.01 Cr | 27.53 Cr |
| Common Stock Equity | 5.88K Cr | 395.71 Cr | 785.45 Cr |
| Total Capitalization | 6.10K Cr | 667.30 Cr | 1.12K Cr |
| Total Equity Gross Minority Interest | 5.88K Cr | 395.71 Cr | 785.45 Cr |
| Stockholders Equity | 5.88K Cr | 395.71 Cr | 785.45 Cr |
| Other Equity Interest | 5.87K Cr | 7.92 Cr | 5.96 Cr |
| Capital Stock | 11.44 Cr | 4.01 Cr | 4.01 Cr |
| Common Stock | 11.44 Cr | 4.01 Cr | 4.01 Cr |
| Retained Earnings | — | -1.82K Cr | -1.43K Cr |
| Additional Paid In Capital | — | 2.20K Cr | 2.20K Cr |
| Other Payable | — | 142.83 Cr | 198.45 Cr |
| Held To Maturity Securities | — | 3.41 Cr | 0.00 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | 0.38 Cr | 0.00 |
| Trading Securities | — | 0.00 | 0.00 |
| Accumulated Depreciation | — | -256.56 Cr | -265.08 Cr |
| Machinery Furniture Equipment | — | 792.50 Cr | 1.23K Cr |
| Buildings And Improvements | — | 127.28 Cr | 182.36 Cr |
| Land And Improvements | — | 19.21 Cr | 15.73 Cr |
| Properties | — | 0.00 | 0.00 |
| Restricted Cash | — | 53.86 Cr | 74.85 Cr |
| Inventories Adjustments Allowances | — | -117.15 Cr | -5.82 Cr |
| Raw Materials | — | 11.23 Cr | 133.16 Cr |
| Other Receivables | — | 5.00 Cr | — |
| Taxes Receivable | — | 13.73 Cr | 2.53 Cr |
| Allowance For Doubtful Accounts Receivable | — | 0.00 | 0.00 |
| Gross Accounts Receivable | — | 55.24 Cr | 3.82 Cr |
| Cash Financial | — | 6.47 Cr | 4.97 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on OneSource Specialty Pharma Inc
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.